127 related articles for article (PubMed ID: 27283127)
1. Exploratory study to evaluate plasma vasopressin and apelin-13 levels in children with attention-deficit hyperactivity disorder.
Bilgiç A; Toker A; Uysal S
Psychiatry Clin Neurosci; 2016 Oct; 70(10):442-447. PubMed ID: 27283127
[TBL] [Abstract][Full Text] [Related]
2. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder.
Bilgiç A; Toker A; Işık Ü; Kılınç İ
Eur Child Adolesc Psychiatry; 2017 Mar; 26(3):355-363. PubMed ID: 27561780
[TBL] [Abstract][Full Text] [Related]
3. Self-inserted foreign body and attention-deficit/hyperactivity disorder: evaluated by the Conners' Parent Rating Scales-Revised.
Özcan K; Özcan Ö; Muluk NB; Cingi C; Durukan K
Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1992-7. PubMed ID: 24139587
[TBL] [Abstract][Full Text] [Related]
4. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
5. Reduced plasma apelin levels in patients with autistic spectrum disorder.
Boso M; Emanuele E; Politi P; Pace A; Arra M; Ucelli di Nemi S; Barale F
Arch Med Res; 2007 Jan; 38(1):70-4. PubMed ID: 17174726
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence.
Deb S; Dhaliwal AJ; Roy M
J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511
[TBL] [Abstract][Full Text] [Related]
7. The genetic and environmental contributions to attention deficit hyperactivity disorder as measured by the Conners' Rating Scales--Revised.
Hudziak JJ; Derks EM; Althoff RR; Rettew DC; Boomsma DI
Am J Psychiatry; 2005 Sep; 162(9):1614-20. PubMed ID: 16135619
[TBL] [Abstract][Full Text] [Related]
8. Iron deficiency in children with attention-deficit/hyperactivity disorder.
Konofal E; Lecendreux M; Arnulf I; Mouren MC
Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1113-5. PubMed ID: 15583094
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
10. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].
Dereboy C; Senol S; Sener S; Dereboy F
Turk Psikiyatri Derg; 2007; 18(1):48-58. PubMed ID: 17364268
[TBL] [Abstract][Full Text] [Related]
11. Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul.
Arman AR; Ersu R; Save D; Karadag B; Karaman G; Karabekiroglu K; Karakoc F; Dagli E; Berkem M
Child Care Health Dev; 2005 Nov; 31(6):707-17. PubMed ID: 16207229
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress contribution to attention deficit hyperactivity disorder in children with epilepsy.
Elhady M; Youness ER; Mostafa RSI; Abdel Aziz A; Hussein R
Appl Neuropsychol Child; 2019; 8(4):347-354. PubMed ID: 30102074
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
14. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD).
Darwish AH; Elgohary TM; Nosair NA
J Child Neurol; 2019 Feb; 34(2):61-67. PubMed ID: 30430896
[TBL] [Abstract][Full Text] [Related]
15. Thyroid and Cortisol hormones in Attention Deficit Hyperactivity Disorder: A case-control study.
Kuppili PP; Pattanayak RD; Sagar R; Mehta M; Vivekanandhan S
Asian J Psychiatr; 2017 Aug; 28():73-77. PubMed ID: 28784401
[TBL] [Abstract][Full Text] [Related]
16. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
Blanchard A; Steichen O; De Mota N; Curis E; Gauci C; Frank M; Wuerzner G; Kamenicky P; Passeron A; Azizi M; Llorens-Cortes C
J Clin Endocrinol Metab; 2013 May; 98(5):2084-9. PubMed ID: 23515451
[TBL] [Abstract][Full Text] [Related]
17. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
[TBL] [Abstract][Full Text] [Related]
18. Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder.
Silva R; Tilker HA; Cecil JT; Kowalik S; Khetani V; Faleck H; Patin J
J Child Adolesc Psychopharmacol; 2004; 14(4):555-63. PubMed ID: 15662147
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).
Shim SH; Hwangbo Y; Kwon YJ; Jeong HY; Lee BH; Lee HJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1824-8. PubMed ID: 18760321
[TBL] [Abstract][Full Text] [Related]
20. Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder.
Oner O; Oner P; Bozkurt OH; Odabas E; Keser N; Karadag H; Kizilgün M
Child Psychiatry Hum Dev; 2010 Aug; 41(4):441-7. PubMed ID: 20238159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
